請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/68814
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 陳為堅(Wei J. Chen) | |
dc.contributor.author | Annemarie Lee Woolston | en |
dc.contributor.author | 李佳螢 | zh_TW |
dc.date.accessioned | 2021-06-17T02:36:43Z | - |
dc.date.available | 2018-08-31 | |
dc.date.copyright | 2017-09-14 | |
dc.date.issued | 2017 | |
dc.date.submitted | 2017-08-17 | |
dc.identifier.citation | Alkelai A, Lupoli S, Greenbaum L, Giegling I, Kohn Y, Sarner-Kanyas K, Ben-Asher E, Lancet D, Rujescu D, Macciardi F, Lerer B (2011). Identification of new schizophrenia susceptibility loci in an ethnically homogeneous, family-based, Arab-Israeli sample. FASEB Journal 25, 4011-4023.
Askland K, Read C, O'Connell C, Moore JH (2012). Ion channels and schizophrenia: a gene set-based analytic approach to GWAS data for biological hypothesis testing. Human Genetics 131, 373-391. Bacanu SA (2012). On optimal gene-based analysis of genome scans. Genetic Epidemiology 36, 333-339. Benyamin B, Visscher PM, McRae AF (2009). Family-based genome-wide association studies. Pharmacogenomics 10, 181-190. Bergen SE, O'Dushlaine CT, Lee PH, Fanous AH, Ruderfer DM, Ripke S, International Schizophrenia Consortium SSC, Sullivan PF, Smoller JW, Purcell SM, Corvin A (2014). Genetic modifiers and subtypes in schizophrenia: investigations of age at onset, severity, sex and family history. Schizophrenia Research 154, 48-53. Bergen SE, Petryshen TL (2012). Genome-wide association studies of schizophrenia: does bigger lead to better results? Current Opinion Psychiatry 25, 76-82. Betcheva ET, Yosifova AG, Mushiroda T, Kubo M, Takahashi A, Karachanak SK, Zaharieva IT, Hadjidekova SP, Dimova, II, Vazharova RV, Stoyanov DS, Milanova VK, Tolev T, Kirov G, Kamatani N, Toncheva DI, Nakamura Y (2013). Whole-genome-wide association study in the Bulgarian population reveals HHAT as schizophrenia susceptibility gene. Psychiatric Genetics 23, 11-19. Bigdeli TB, Bacanu SA, Webb BT, Walsh D, O'Neill FA, Fanous AH, Riley BP, Kendler KS (2014). Molecular validation of the schizophrenia spectrum. Schizophrenia Bulletin 40, 60-65. Birtwistle J, Baldwin D (1998). Role of dopamine in schizophrenia and Parkinson's disease. British Journal of Nursing 7, 832-834, 836, 838-841. Bromet EJ, Fennig S (1999). Epidemiology and natural history of schizophrenia. Biological Psychiatry 46, 871-881. Bruggemann N, Klein C (1993). Parkin type of early-onset Parkinson disease. In Gene Reviews (ed. R. A. Pagon): Seattle (WA). Cardno AQ, Thomas T, McQuffin P (2002). Clinical variables and genetic loading for schizophrenia- analysis of published Danish adoption study data. Schizophrenia Bulletin 28, 393-399. Chang A, Fox SH (2016). Psychosis in Parkinson's disease: Epidemiology, pathophysiology, and management. Drugs 76, 1093-1118. Chang SS, Liu CM, Lin SH, Hwu HG, Hwang TJ, Liu SK, Hsieh MH, Guo SC, Chen WJ (2009). Impaired flush response to niacin skin patch among schizophrenia patients and their nonpsychotic relatives: the effect of genetic loading. Schizophrenia Bulletin 35, 213-221. Chen WJ, Liu SK, Chang CJ, Lien YJ, Chang YH, Hwu HG (1998). Sustained attention deficit and schizotypal personality features in nonpsychotic relatives of schizophrenic patients. American Journal of Psychiatry 155, 1214-1220. Chien IC, Chou YJ, Lin CH, Bih SH, Chou P, Chang HJ (2004). Prevalence and incidence of schizophrenia among national health insurance enrollees in Taiwan, 1996–2001. Journal of Neuropsychiatry and Clinical Neurosciences 58, 611-618. Cho MJ, Lee BD, Kim C (2015). Pilot study for family-based association analysis of schizophrenia in a Korean population: Analysis for candidate genes positionally on chromosome 18q21. Asia-Pacific Psychiatry 7, 268-275. Derks EM, Verweij KH, Kahn RS, Cahn WC (2009). The calculation of familial loading in schizophrenia. Schizophrenia Research 111, 198-199. Dudbridge F, Gusnanto A (2008). Estimation of significance thresholds for genomewide association scans. Genetic Epidemiology 32, 227-234. Edwards AC, Bigdeli TB, Docherty AR, Bacanu S, Lee D, de Candia TR, Moscati A, Thiselton DL, Maher BS, Wormley BK, Molecular Genetics of Schizophrenia C, Walsh D, O'Neill FA, Kendler KS, Riley BP, Fanous AH (2016). Meta-analysis of positive and negative symptoms reveals schizophrenia modifier genes. Schizophrenia Bulletin 42, 279-287. Fanous AH, Chen X, Wang X, Amdur RL, O'Neill FA, Walsh D, Kendler KS (2007). Association between the 5q31.1 gene neurogenin1 and schizophrenia. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 144B, 207-214. Fanous AH, Kendler KS (2005). Genetic heterogeneity, modifier genes, and quantitative phenotypes in psychiatric illness: searching for a framework. Molecular Psychiatry 10, 6-13. Fanous AH, Zhou B, Aggen SH, Bergen SE, Amdur RL, Duan J, Sanders AR, Shi J, Mowry BJ, Olincy A, Amin F, Cloninger CR, Silverman JM, Buccola NG, Byerley WF, Black DW, Freedman R, Dudbridge F, Holmans PA, Ripke S, Gejman PV, Kendler KS, Levinson DF, Schizophrenia Psychiatric Genome-Wide Association Study C (2012). Genome-wide association study of clinical dimensions of schizophrenia: polygenic effect on disorganized symptoms. American Journal of Psychiatry 169, 1309-1317. Faraone SV, Hwu HG, Liu CM, Chen WJ, Tsuang MM, Liu SK, Shieh MH, Hwang TJ, Ou-Yang WC, Chen CY, Chen CC, Lin JJ, Chou FH, Chueh CM, Liu WM, Hall MH, Su J, Van Eerdewegh P, Tsuang MT (2006). Genome scan of Han Chinese schizophrenia families from Taiwan: confirmation of linkage to 10q22.3. American Journal of Psychiatry 163, 1760-1766. Gershon ES, Alliey-Rodriguez N, Liu C (2011). After GWAS: searching for genetic risk for schizophrenia and bipolar disorder. American Journal of Psychiatry 168, 253-256. Gibson G (2010). Hints of hidden heritability in GWAS. Nature Genetics 42, 558-560. Gibson G (2012). Rare and common variants: twenty arguments. Nature Review Genetics 13, 135-145. Glausier JR, Lewis DA (2013). Dendritic spine pathology in schizophrenia. Neuroscience 251, 90-107. Gottesman I, Shields J (1967). A polygenic theory of schizophrenia. Proceedings of the National Academy of Sciences 58, 199-205. Gratten J (2016). Rare variants are common in schizophrenia. Nature Neuroscience 19, 1426-1428. Grimes DA, Bulman DE (2002). Parkinson's genetics--creating exciting new insights. Parkinsonism and Related Disorders 8, 459-464. Holliday EG, Nyholt DR, Tirupati S, John S, Ramachandran P, Ramamurti M, Ramadoss AJ, Jeyagurunathan A, Kottiswaran S, Smith HJ, Filippich C, Nertney DA, Nancarrow DJ, Hayward NK, Watkins WS, Jorde LB, Thara R, Mowry BJ (2009). Strong evidence for a novel schizophrenia risk locus on chromosome 1p31.1 in homogeneous pedigrees from Tamil Nadu, India. American Journal of Psychiatry 166, 206-215. Hong KS, Won HH, Cho EY, Jeun HO, Cho SS, Lee YS, Park DY, Jang YL, Choi KS, Lee D, Kim MJ, Kim S, Han WS, Kim JW (2009). Genome-widely significant evidence of linkage of schizophrenia to chromosomes 2p24.3 and 6q27 in an SNP-Based analysis of Korean families. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 150B, 647-652. Hwu HG, Faraone SV, Liu CM, Chen WJ, Liu SK, Shieh MH, Hwang TJ, Tsuang MM, OuYang WC, Chen CY, Chen CC, Lin JJ, Chou FH, Chueh CM, Liu WM, Hall MH, Tsuang MT (2005). Taiwan schizophrenia linkage study: the field study. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 134B, 30-36. Jin L, Zuo XY, Su WY, Zhao XL, Yuan MQ, Han LZ, Zhao X, Chen YD, Rao SQ (2014). Pathway-based analysis tools for complex diseases: a review. Genomics Proteomics Bioinformatics 12, 210-220. Johnson RC, Nelson GW, Troyer JL, Lautenberger JA, Kessing BD, Winkler CA, O'Brien SJ (2010). Accounting for multiple comparisons in a genome-wide association study (GWAS). BMC Genomics 11, 724. Jones HJ, Stergiakouli E, Tansey KE, Hubbard L, Heron J, Cannon M, Holmans P, Lewis G, Linden DE, Jones PB, Davey Smith G, O'Donovan MC, Owen MJ, Walters JT, Zammit S (2016). Phenotypic manifestation of genetic risk for schizophrenia during adolescence in the general population. JAMA Psychiatry 73, 221-228. Kapelski P, Skibinska M, Maciukiewicz M, Zaremba D, Jasiak M, Hauser J (2016). Family association study of Transforming Growth Factor Beta1 gene polymorphisms in schizophrenia. Psychiatria Polska 50, 761-770. Kebir O, Chaumette B, Fatjo-Vilas M, Ambalavanan A, Ramoz N, Xiong L, Mouaffak F, Millet B, Jaafari N, DeLisi LE, Levinson D, Joober R, Fananas L, Rouleau G, Dubertret C, Krebs MO (2014). Family-based association study of common variants, rare mutation study and epistatic interaction detection in HDAC genes in schizophrenia. Schizophrenia Research 160, 97-103. Kendler KS (1988). Familial Aggregation of Schizophrenia and Schizophrenia Spectrum Disorders- Evaluation of Conflicting Results. Archives of General Psychiatry 45, 377-383. Kim SY, Volsky DJ (2005). PAGE: parametric analysis of gene set enrichment. BMC Bioinformatics 6, 144. Kim Y, Zerwas S, Trace SE, Sullivan PF (2011). Schizophrenia genetics: where next? Schizophrenia Bulletin 37, 456-463. Kinney DK, Hintz K, Shearer EM, Barch DH, Riffin C, Whitley K, Butler R (2010). A unifying hypothesis of schizophrenia: Abnormal immune system development may help explain roles of prenatal hazards, post-pubertal onset, stress, genes, climate, infections, and brain dysfunction. Medical Hypotheses 74, 555-563. Knapp M, Mangalore R, Simon J (2004). The global costs of schizophrenia. Schizophrenia Bulletin 30, 279093. Laird NM, Lange C (2008). Family-based methods for linkage and association analysis. Advances in Genetics 60, 219-252. Lasky-Su J, Lange C, Biederman J, Tsuang M, Doyle AE, Smoller JW, Laird N, Faraone S (2008). Family-based association analysis of a statistically derived quantitative traits for ADHD reveal an association in DRD4 with inattentive symptoms in ADHD individuals. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 147B, 100-106. Lewis DA, Lieberman JA (2000). Catching Up on Schizophrenia:Natural History and Neurobiology. Neuron 28, 325-334. Lien YJ, Hsiao PC, Liu CM, Faraone SV, Tsuang MT, Hwu HG, Chen WJ (2011). A genome-wide linkage scan for distinct subsets of schizophrenia characterized by age at onset and neurocognitive deficits. Public Library of Science One 6, e24103. Lucking CB, Durr A, Bonifati V, Vaughan J, De Michele G, Gasser T, Harhangi BS, Meco G, Denefle P, Wood NW, Agid Y, Brice A, French Parkinson's Disease Genetics Study G, European Consortium on Genetic Susceptibility in Parkinson's D (2000). Association between early-onset Parkinson's disease and mutations in the parkin gene. New England Journal of Medicine 342, 1560-1567. Manichaikul A, Mychaleckyj JC, Rich SS, Daly K, Sale M, Chen WM (2010). Robust relationship inference in genome-wide association studies. Bioinformatics 26, 2867-2873. McClellan J, King MC (2010). Genetic heterogeneity in human disease. Cell 141, 210-217. Messias EL, Chen CY, Eaton WW (2007). Epidemiology of schizophrenia: review of findings and myths. Psychiatric Clinics of North America 30, 323-338. Mishra A, Macgregor S (2015). VEGAS2: Software for More Flexible Gene-Based Testing. Twin Research and Human Genetics 18, 86-91. Mooney MA, Wilmot B (2015). Gene set analysis: A step-by-step guide. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 168, 517-527. Mortensen PB, Pedersen CB, Westergaard T, Wohlfahrt J, Ewald H, Mors O, Andersen PK, Melbye M (1999). Effects of family history and place and season of birth on the risk of schizophrenia. New England Journal of Medicine 340, 603. Mukherjee O, Meera P, Ghosh S, Kubendran S, Kiran K, Manjunath KR, Subhash MN, Benegal V, Brahmachari SK, Majumder PP, Jain S (2006). Evidence of linkage and association on 18p11.2 for psychosis. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 141B, 868-873. Muller N, Schwarz MJ (2010). Immune system and schizophrenia. Current Immunology Reviews 6, 213-220. Nam D, Kim J, Kim SY, Kim S (2010). GSA-SNP: a general approach for gene set analysis of polymorphisms. Nucleic Acids Research 38, W749-754. Neale BM, Sham PC (2004). The future of association studies: gene-based analysis and replication. American Journal of Human Genetics 75, 353-362. Neale BM, Sham PC, Purcell S, Banaschewski T, Buitelaar J, Franke B, Sonuga-Barke E, Ebstein R, Eisenberg J, Mulligan A, Gill M, Manor I, Miranda A, Mulas F, Oades RD, Roeyers H, Rothenberger A, Sergeant J, Steinhausen HC, Taylor E, Thompson M, Chen W, Zhou K, Asherson P, Faraone SV (2008). Population differences in the International Multi-Centre ADHD Gene Project. Genetic Epidemiology 32, 98-107. Ng MY, Levinson DF, Faraone SV, Suarez BK, DeLisi LE, Arinami T, Riley B, Paunio T, Pulver AE, Irmansyah, Holmans PA, Escamilla M, Wildenauer DB, Williams NM, Laurent C, Mowry BJ, Brzustowicz LM, Maziade M, Sklar P, Garver DL, Abecasis GR, Lerer B, Fallin MD, Gurling HM, Gejman PV, Lindholm E, Moises HW, Byerley W, Wijsman EM, Forabosco P, Tsuang MT, Hwu HG, Okazaki Y, Kendler KS, Wormley B, Fanous A, Walsh D, O'Neill FA, Peltonen L, Nestadt G, Lasseter VK, Liang KY, Papadimitriou GM, Dikeos DG, Schwab SG, Owen MJ, O'Donovan MC, Norton N, Hare E, Raventos H, Nicolini H, Albus M, Maier W, Nimgaonkar VL, Terenius L, Mallet J, Jay M, Godard S, Nertney D, Alexander M, Crowe RR, Silverman JM, Bassett AS, Roy MA, Merette C, Pato CN, Pato MT, Roos JL, Kohn Y, Amann-Zalcenstein D, Kalsi G, McQuillin A, Curtis D, Brynjolfson J, Sigmundsson T, Petursson H, Sanders AR, Duan J, Jazin E, Myles-Worsley M, Karayiorgou M, Lewis CM (2009). Meta-analysis of 32 genome-wide linkage studies of schizophrenia. Molecular Psychiatry 14, 774-785. Nguyen TT, Huang J, Wu Q, Nguyen T, Li M (2015). Genome-wide association data classification and SNPs selection using two-stage quality-based Random Forests. BMC Genomics 16 Suppl 2, S5. NIMH Genetics Initiative & Rockville MD (1992). Family interview for genetic studies. National Institute of Mental Health. Nsengimana J, Bishop DT (2012). Design considerations for genetic linkage and association studies. Methods in Molecular Biology 850, 237-262. Nurnberger JI, Jr., Blehar MC, Kaufmann CA, York-Cooler C, Simpson SG, Harkavy-Friedman J, Severe JB, Malaspina D, Reich T (1994). Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Archives of General Psychiatry 51, 849-859; discussion 863-844. O'Dushlaine C, Kenny E, Heron E, Donohoe G, Gill M, Morris D, International Schizophrenia C, Corvin A (2011). Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility. Molecular Psychiatry 16, 286-292. Owen MJ, Craddock N, O'Donovan MC (2010). Suggestion of roles for both common and rare risk variants in genome-wide studies of schizophrenia. Archives of General Psychiatry 67, 667-673. Pan WH, Fann CS, Wu JY, Hung YT, Ho MS, Tai TH, Chen YJ, Liao CJ, Yang ML, Cheng AT, Chen YT (2006). Han Chinese cell and genome bank in Taiwan: purpose, design and ethical considerations. Human Heredity 61, 27-30. Perroud N, Uher R, Ng MY, Guipponi M, Hauser J, Henigsberg N, Maier W, Mors O, Gennarelli M, Rietschel M, Souery D, Dernovsek MZ, Stamp AS, Lathrop M, Farmer A, Breen G, Aitchison KJ, Lewis CM, Craig IW, McGuffin P (2012). Genome-wide association study of increasing suicidal ideation during antidepressant treatment in the GENDEP project. Pharmacogenomics Journal 12, 68-77. Picchioni MM, Murray RM (2007). Schizophrenia. British Medical Journal 335, 91-95. Pickard B (2011). Progress in defining the biological causes of schizophrenia. Expert Reviews in Molecular Medicine 13, e25. Pirinen M, Donnelly P, Spencer CC (2012). Including known covariates can reduce power to detect genetic effects in case-control studies. Nature Genetics 44, 848-851. Pruim RJ, Welch RP, Sanna S, Teslovich TM, Chines PS, Gliedt TP, Boehnke M, Abecasis GR, Willer CJ (2010). LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 26, 2336-2337. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, Maller J, Sklar P, de Bakker PIW, Daly MJ, Sham PC (2007). PLINK: A tool set for whole-genome association and population-based linkage analyses. American Journal of Human Genetics 81, 559-575. Roussos P, Mitchell AC, Voloudakis G, Fullard JF, Pothula VM, Tsang J, Stahl EA, Georgakopoulos A, Ruderfer DM, Charney A, Okada Y, Siminovitch KA, Worthington J, Padyukov L, Klareskog L, Gregersen PK, Plenge RM, Raychaudhuri S, Fromer M, Purcell SM, Brennand KJ, Robakis NK, Schadt EE, Akbarian S, Sklar P (2014). A role for noncoding variation in schizophrenia. Cell Reports 9, 1417-1429. Ruderfer DM, Kirov G, Chambert K, Moran JL, Owen MJ, O'Donovan MC, Sklar P, Purcell SM (2011). A family-based study of common polygenic variation and risk of schizophrenia. Molecular Psychiatry 16, 887-888. Saha S, Chant D, Welham J, McGrath J (2005). A systematic review of the prevalence of schizophrenia. PLoS Medicine 2, e141. Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014). Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421-427. Schultz SW, North SW, Cleveland GS (2007). Schizophreina: a review. American Family Physician 75, 1821-1829. Sengupta SM, MacDonald K, Fathalli F, Yim A, Lepage M, Iyer S, Malla A, Joober R (2016). Polygenic Risk Score associated with specific symptom dimensions in first-episode psychosis. Schizophrenia Research Available online 2 December 2016, DOI: 10.1016/j.schres.2016.1011.1039. Shao W, Halachmi S, Brown M (2002). ERAP140, a conserved tissue-specific nuclear receptor coactivator. Molecular and Cellular Biology 22, 3358-3372. Sullivan PF, Kendler KS, Neale MC (2003). Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Archives of General Psychiatry 60, 1187-1192. Sullivan PF, Lin D, Tzeng JY, van den Oord E, Perkins D, Stroup TS, Wagner M, Lee S, Wright FA, Zou F, Liu W, Downing AM, Lieberman J, Close SL (2008). Genomewide association for schizophrenia in the CATIE study: results of stage 1. Molecular Psychiatry 13, 570-584. Suvisaari J, Haukka J, Tanskanen A, Lonnqvist JK (1998). Age at onset and outcome in schizophrenia are related to the degree of familial loading. Svishcheva GR, Belonogova NM, Axenovich TI (2014). FFBSKAT: fast family-based sequence kernel association test. PLoS One 9, e99407. Tang JX, Zhou J, Fan JB, Li XW, Shi YY, Gu NF, Feng GY, Xing YL, Shi JG, He L (2003). Family-based association study of DTNBP1 in 6p22.3 and schizophrenia. Molecular Psychiatry 8, 717-718. The International Schizophrenia Consortium, Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF, Sklar P (2009). Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460, 748-752. Tsuang HC, Lin SH, Liu SK, Hsieh MH, Hwang TJ, Liu CM, Hwu HG, Chen WJ (2006). More severe sustained attention deficits in nonpsychotic siblings of multiplex schizophrenia families than in those of simplex ones. Schizophrenia Research 87, 172-180. Tsuang M (2000). Schizophrenia: genes and environment. Biological Psychiatry 47, 210-220. Turner S, Armstrong LL, Bradford Y, Carlson CS, Crawford DC, Crenshaw AT, de Andrade M, Doheny KF, Haines JL, Hayes G, Jarvik G, Jiang L, Kullo IJ, Li R, Ling H, Manolio TA, Matsumoto M, McCarty CA, McDavid AN, Mirel DB, Paschall JE, Pugh EW, Rasmussen LV, Wilke RA, Zuvich RL, Ritchie MD (2011). Unit1.19:Quality control procedures for genome-wide association studies. Current Protocols in Human Genetics. van Os J, Kapur S (2009). Schizophrenia. Lancet 374, 635-645. Vassos E, Di Forti M, Coleman J, Iyegbe C, Prata D, Euesden J, O'Reilly P, Curtis C, Kolliakou A, Patel H, Newhouse S, Traylor M, Ajnakina O, Mondelli V, Marques TR, Gardner-Sood P, Aitchison KJ, Powell J, Atakan Z, Greenwood KE, Smith S, Ismail K, Pariante C, Gaughran F, Dazzan P, Markus HS, David AS, Lewis CM, Murray RM, Breen G (2016). An examination of polygenic score risk prediction in individuals with first-episode psychosis. Biological Psychiatry. Wang KS, Liu X, Zhang Q, Aragam N, Pan Y (2011). Genome-wide association analysis of age at onset in schizophrenia in a European-American sample. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 156B, 671-680. Williams HJ, Norton N, Dwyer S, Moskvina V, Nikolov I, Carroll L, Georgieva L, Williams NM, Morris DW, Quinn EM, Giegling I, Ikeda M, Wood J, Lencz T, Hultman C, Lichtenstein P, Thiselton D, Maher BS, Molecular Genetics of Schizophrenia Collaboration International Schizophrenia Consortium S-pG, Malhotra AK, Riley B, Kendler KS, Gill M, Sullivan P, Sklar P, Purcell S, Nimgaonkar VL, Kirov G, Holmans P, Corvin A, Rujescu D, Craddock N, Owen MJ, O'Donovan MC (2011). Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder. Molecular Psychiatry 16, 429-441. Woolston AL, Hsiao PC, Kuo PH, Wang SH, Lien YJ, Liu CM, Hwu HG, Lu TP, Chuang EY, Chang LC, Chen CH, Wu JY, Tsuang MT, Chen WJ (2017). Genetic loci associated with an earlier age at onset in multiplex schizophrenia. Scientific Reports 7, 6486. Wray NR, Lee SH, Mehta D, Vinkhuyzen AA, Dudbridge F, Middeldorp CM (2014). Research review: Polygenic methods and their application to psychiatric traits. Journal of Child Psychology and Psychiatry 55, 1068-1087. Yamada K, Iwayama Y, Hattori E, Iwamoto K, Toyota T, Ohnishi T, Ohba H, Maekawa M, Kato T, Yoshikawa T (2011). Genome-wide association study of schizophrenia in Japanese population. PLoS One 6, e20468. Yue WH, Wang HF, Sun LD, Tang FL, Liu ZH, Zhang HX, Li WQ, Zhang YL, Zhang Y, Ma CC, Du B, Wang LF, Ren YQ, Yang YF, Hu XF, Wang Y, Deng W, Tan LW, Tan YL, Chen Q, Xu GM, Yang GG, Zuo XB, Yan H, Ruan YY, Lu TL, Han X, Ma XH, Wang Y, Cai LW, Jin C, Zhang HY, Yan J, Mi WF, Yin XY, Ma WB, Liu Q, Kang L, Sun W, Pan CY, Shuang M, Yang FD, Wang CY, Yang JL, Li KQ, Ma X, Li LJ, Yu X, Li QZ, Huang X, Lv LX, Li T, Zhao GP, Huang W, Zhang XJ, Zhang D (2011). Genome-wide association study identifies a susceptibility locus for schizophrenia in Han Chinese at 11p11.2. Nature Genetics 43, 1228-1231. Zaitlen N, Kraft P (2012). Heritability in the genome-wide association era. Human Genetics 131, 1655-1664. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/68814 | - |
dc.description.abstract | 背景:思覺失調症是個由複雜遺傳因子構成致病機轉之精神疾病,其高度多基因遺傳架構包含了易感受性與修飾基因,構成此疾病之遺傳異質性。全基因體關聯性研究之間不一致的結果顯示,有數百個遺傳基因座與思覺失調症之易感受性之間有關聯性,此議題已被認為是相當大的隱憂。根據和遺傳負荷相關的特徵將患者分組的關聯性分析,可以提供有效的方法來尋找與台灣漢人之思覺失調症相關的修飾及易感受性基因。
研究目的:此研究的主旨在於,1)辨識與思覺失調症較早發年齡相關之修飾基因座;2)在台灣漢人族群中尋找與思覺失調症易感受性相關之單核苷酸多型性、基因、基因群、以及路徑;3)在思覺失調症較早發病多發家庭中以常見及罕見變異探討與易感受性相關的遺傳因子。 方法:本篇論文建構三種研究設計來達到不同的目的。第一、從557個多發性家庭中挑選出來的94個最早發病與91個最晚發病之思覺失調症指標患者,被用來進行一個只有病例的全基因體關聯性研究。接著在這些沒有親屬關係之患者的共病手足中,進行候選單核苷酸多型性的基因定型。由候選基因座所組成的多基因遺傳風險評分,被用來區別最早發病與最晚發病之指標患者。第二、這185個指標患者接下來被混合成為一群病例,將其與925個正常對照組座,進行單核苷酸多型性基因型的比較。包括1)個別單核苷酸多型性關聯檢驗;2)基因基礎分析;3)基因群富集分析等三種策略,被用來詮釋思覺失調症易感受性之全基因體關聯性研究資料。第三、運用針對精神疾病設計的基因型定序晶片,較早發病的思覺失調症多發性家庭中,檢測常見與罕見遺傳因子,並進行家族遺傳研究。 結果:在與思覺失調症較早發病年齡相關之修飾基因座方面,由14個單核苷酸多型性組成之風險分數,可以區分最早發病指標患者之90位共病手足與最晚發病指標患者之91位共病手足。當132次早發病患者與158為次晚發病患者皆被納入分析後,在最早、次早、次晚、最晚發病年齡等四組家庭群體之間,此由14個單核苷酸多型性組成之風險分數具有一個顯著的趨勢。這些基因座初步的網絡分析顯示PARK2這個經常在思覺失調症被報導的,被認為是導致帕金森氏症較早發病的基因之參與。而與思覺失調症易感受性有關之遺傳組成方面,在一開始的全基因體基因關聯性研究中,辨識出四個通過全基因體顯著水準。而LINC01215、 IFT57、及CD47等三個有最強訊號的基因可在Psychiatric Genomics consortium – Schizophrenia 2 (PGC-SCZ2)中重現,一個京都基因與基因组百科全書路徑(KEGG pathway)- 細胞附著分子(Cell adhesion molecules,CAM),以及十四個集中在神經元細胞形成、離子閥門通道、免疫反應活性等基因本體論關係(GO terms)也在基因組富集分析中被找到。在家族相關性研究方面,根據思覺失調症遺傳架構的多基因概念,超過兩百個基因全基因體相關性研究被篩選出來,進行路徑與網絡分析。常見與罕見變異都被納入考量,同時對較早發病年齡的多發性家庭之思覺失調症易感受性具有貢獻。 結論:在本論文中包含的這些研究辨識出,1)與思覺失調症的較早發病年齡相關之修飾基因座,2)在臺灣漢人族群中,與思覺失調症易感受性相關的單核苷酸多型性、基因、基因群、生物路徑,3)於較早發病的多發性家庭中,許多潛在與思覺失調症易感受性相關的基因、路徑、網絡等。許多個不同面向的遺傳因子,可能可以進一步幫助闡釋思覺失調症的致病機轉。 | zh_TW |
dc.description.abstract | Background: Schizophrenia is a mental disorder resulted from complex genetic components underpinning the pathogenesis. The highly polygenic architecture, including susceptibility and modifier genes, results in genetic heterogeneity of schizophrenia. Inconsistent results between genome-wide association studies (GWAS) have reported possible associations between hundreds of genetic loci with variants and susceptibility of schizophrenia. This issue has been a major concern in recent genomic studies. Association analyses based on subgrouping patients according to characteristics related to genetic loadings may provide an efficient way to search for modifier and susceptibility genes in multiplex schizophrenia in Taiwanese Han population.
Aims: This study aimed 1) to identify modifier loci associated with an earlier AAO of schizophrenia; 2) to search for single nucleotide polymorphisms (SNPs), genes, and gene sets associated with susceptibility for schizophrenia among Taiwanese population; and 3) to investigate susceptibility-related genetic components using both common and variants among multiplex families with early age at onset of schizophrenia. Methods: Three study designs were conducted to achieve different aims. First, a case-only GWAS was conducted in 94 schizophrenia probands with the earliest AAO and 91 with the latest AAO selected from 557 multiplex families. Candidate single nucleotide polymorphisms (SNPs) were then genotyped in the co-affected siblings and unrelated probands. Multi-SNP risk scores composed of the candidate loci were used to distinguish patients with an early or late AAO. Second, the 185 probands were then pooled together to be a group of cases and compared the SNP genotypes with a total of 925 normal controls. Three analytic methods including 1) individual SNP association tests; 2) gene-based analysis; and 3) gene set enrichment analysis were used to interpret the GWAS dataset for susceptibility for schizophrenia. Third, family-based association tests on genome-wide common and rare variants, utilizing genotyping microarray designed for psychiatric diseases, were performed among multiplex families with earlier age at onset of schizophrenia. Results: For modifier loci associated with AAO of schizophrenia, the 14-SNP risk score could distinguish the co-affected siblings (n = 90) of the earliest AAO probands from those (n = 91) of the latest AAO probands. When 132 patients with an earlier AAO and 158 patients with a later AAO were included, a significant trend in the 14-SNP risk score was detected among those unrelated probands from 4 family groups with the earliest, earlier, later, and latest AAO. Preliminary network analysis of these loci revealed the involvement of PARK2, a gene known as main cause of early-onset Parkinson’s disease and intensively reported in schizophrenia research. For genetic components related to susceptibility for schizophrenia, 4 SNPs passed genome-wide significance (p < × 10-8) in the initial GWAS. Three genes, LINC01215, IFT57, and CD47 with associations (p < 0.001) in Taiwanese population were replicated in the Psychiatric Genomics consortium – Schizophrenia 2 (PGC-SCZ2) samples. A KEGG pathway, Cell adhesion molecules (CAM) and 14 gene ontology (GO) terms focusing on neural formation, ion-gated channels, and immune response activities were identified overlapping with the PGC-SCZ2 dataset. For the family-based association analyses, over two hundred genes were shortlisted from the GWAS results based on the concept of the polygenic architecture of schizophrenia. Both common or rare variants were considered having contribution to the susceptibility within multiplex families with early age at onset. The pathway analysis and network analysis according to these genes revealed 17 significant (P < 0.05) biological pathways and 8 networks each included more than 10 genes out of the gene lists. Conclusion: The studies included in this doctoral dissertation have identified 1) modifier loci associated with an earlier AAO of schizophrenia; 2) associations of SNPs, genes, gene sets, and pathways with susceptibility for schizophrenia among the Taiwanese Han population; and 3) a long list of genes, pathways, and networks potentially associated with susceptibility for schizophrenia among multiplex families with early age at onset. The genetic components with different dimensions may help further illuminate the pathogenesis of schizophrenia. | en |
dc.description.provenance | Made available in DSpace on 2021-06-17T02:36:43Z (GMT). No. of bitstreams: 1 ntu-106-D99849006-1.pdf: 3094492 bytes, checksum: c14a5174e1cca40c60cbbc70c969bf8d (MD5) Previous issue date: 2017 | en |
dc.description.tableofcontents | Chinese Abstract: i
English Abstract: iv Contents: vii Chapter 1. Background 1.1 Schizophrenia: 1 1.2 Genetic Basis of Schizophrenia: 1 1.3 Genome-Wide Scan for Variations: 1 1.4 Heterogeneity of schizophrenia: 2 1.5 Overview: 3 Chapter 2. Genetic Loci Associated with An Earlier Age at Onset in Multiplex Schizophrenia 2.1 Introduction: 5 2.2 Materials and Methods: 7 2.3 Results: 13 2.4 Discussion: 17 2.5 Tables and Figures: 23 Chapter 3. Gene-Based and Gene Set Enrichment Analysis on A Case-Control Genome-Wide Association Study for Multiplex Schizophrenia in Taiwan Han Population 3.1 Introduction: 33 3.2 Materials and Methods: 36 3.3 Results: 40 3.4 Discussion: 43 3.5 Tables and Figures: 47 Chapter 4. Family-Based Association Analyses Incorporating Both Common and Rare Variants among Multiplex Schizophrenia Families with Early Age at Onset 4.1 Introduction: 54 4.2 Materials and Methods: 57 4.3 Results: 60 4.4 Discussion: 62 4.5 Tables and Figures: 64 Chapter 5. Conclusions and Implications: 83 References 85 | |
dc.language.iso | en | |
dc.title | 利用全基因體關聯掃描探討與多發性思覺失調症及其較早發病年齡相關之遺傳變異 | zh_TW |
dc.title | Investigation of Genetic Variants Associated with Multiplex Schizophrenia and Its Early Age at Onset using Genome-Wide Association Studies | en |
dc.type | Thesis | |
dc.date.schoolyear | 105-2 | |
dc.description.degree | 博士 | |
dc.contributor.oralexamcommittee | 郭炤裕(Chao-Yu Guo),劉智民(Chih-Min Liu),郭柏秀(Po-Hsiu Kuo),盧子彬(Tzu-Pin Lu),俞松良(Sung-Liang Yu) | |
dc.subject.keyword | 多發性思覺失調症,家族病史,發病年齡,易感受性,全基因體關聯性研究,多基因遺傳風險評分,基因基礎分析,基因群富集分析, | zh_TW |
dc.subject.keyword | multiplex schizophrenia family history,age at onset,susceptibility,GWAS,polygenic risk scores,gene-based analysis,gene set enrichment analysis, | en |
dc.relation.page | 100 | |
dc.identifier.doi | 10.6342/NTU201703657 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2017-08-17 | |
dc.contributor.author-college | 公共衛生學院 | zh_TW |
dc.contributor.author-dept | 流行病學與預防醫學研究所 | zh_TW |
顯示於系所單位: | 流行病學與預防醫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-106-1.pdf 目前未授權公開取用 | 3.02 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。